Also known as Neusignal Therapeutics Inc..
None yet. When a new project in the record names Neusignal Therapeutics as owner, partner or investor, it shows here.
End-to-end CDMO support for NTX-083 completed — manufacturing process established and IND CMC documentation prepared ahead of planned US clinical trials in 2026.
